Balyasny Asset Management LLC Biogen Inc. Put Options Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $23.3 Million - $30.8 Million	-90,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $8.87 Million - $11.3 Million	33,000 Added 57.89%	90,000 $28.5 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $16.7 Million - $21.9 Million	57,000 New	57,000 $19.3 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.